Tourette’s Study for Adults
$75 per completed visit
Study Specific Details:
- Gemlapodect vs. Placebo. This is a double-blind, placebo-controlled study to evaluate the safety and efficacy of Gemlapodect in teens and adults.
- 3-month treatment period.
- Fasting at screening is not required.
- Participants are reimbursed $75 for their time and travel at the end of each completed visit.
- Must be 19 years or older to participate.
- Must exhibit moderate to severe tics.
- Medication for the treatment of motor or vocal tics will have a 14-day washout period prior to baseline.
- Fasting at screening is optional.
- Current severe anxiety, bipolar disorder, schizophrenia.
- Comorbid conditions such as OCD, ADHD, GAD and MDD are allowed as long as their symptoms have been stable for at least 1 month.
- Known diagnosis of substance abuse or dependence.
- Suicidal ideation or behavior
- Uncontrolled seizure disorder, TBI, stroke, Huntington's disease, Parkinson's disease, Wilson's disease, stroke, and Restless legs Syndrome.
Questions? Give Us A Call!
Contact Us
Want to learn more about Harmonex Neuroscience Research?